| Autor: |
Sheng QJ; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Liaoning Province Key Laboratory of Viral Hepatitis, Shenyang 110022, China., Dou XG; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Liaoning Province Key Laboratory of Viral Hepatitis, Shenyang 110022, China. |
| Jazyk: |
čínština |
| Zdroj: |
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2023 Mar 20; Vol. 31 (3), pp. 225-227. |
| DOI: |
10.3760/cma.j.cn501113-20230217-00064 |
| Abstrakt: |
Timely and effective antiviral therapy can prevent or delay the progression of the disease to cirrhosis, liver failure, or hepatocellular carcinoma in patients with chronic hepatitis B. Antiviral therapy indications are constantly expanding, and eventually it will be manageable to treat viral positives based on the new understanding of the disease progression and the changes in the definition of abnormal values in liver function tests. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
